首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1559165

RNA定序：各種技術和全球市場

RNA Sequencing: Technologies and Global Markets

出版日期: 2024年09月20日 | 出版商:

BCC Research | 英文 166 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球RNA定序市場規模預計將從2024年的43億美元成長到2029年終的103億美元，預測期內複合年成長率為19.1%。

工具和試劑產業預計將從 2024 年的 30 億美元成長到 2029年終的74 億美元，複合年成長率為 19.6%。此外，設備產業預計將從2024年的6.456億美元成長到2029年終的15億美元，複合年成長率為18.2%。

該報告調查了全球RNA定序市場，並提供了市場概況、市場影響因素和市場機會、法律制度、新興技術和技術發展趨勢、市場規模趨勢和預測、各個細分市場和地區的分析、競爭格局、主要企業概況等。

市場動態
市場促進因素
資料分析能力快速進步
基因組學和生物醫學研究的有利資金籌措方案
基因組定序價格更低
由於癌症發生率增加，對個人化治療的需求增加
市場限制因素
缺乏資料標準化
成本和覆蓋範圍挑戰
市場機會
區塊鏈和雲端運算技術的運用
RNA 分離與萃取製程的技術進步

第4章新興科技與發展

單細胞RNA定序
其他新的單細胞技術

第5章市場區隔分析

主要市場趨勢
細分細分
全球 RNA定序市場：依產品
裝置
工具/試劑
軟體服務
全球 RNA定序市場：依技術分類
合成定序
離子激流半導體定序
單分子即時定序
奈米孔定序
全球RNA定序市場：依應用分類
表達譜分析
小RNA定序
從頭轉錄組組裝
變異調用和轉錄組表觀遺傳學
全球 RNA定序市場：依最終用戶分類
學術研究所
製藥和生物技術公司
臨床實驗室/醫院實驗室
其他
地域分佈
全球RNA定序市場：按地區
北美洲
歐洲
亞太地區
其他領域

第6章競爭訊息

概述
主要企業排名
企業招募策略
合作與合約
新產品發布
夥伴關係
擴張
M&A
CRO 在 RNA定序資料產生中的作用
領先的RNA定序服務供應商

第 7 章 RNA定序市場的永續性：ESG 視角

ESG：簡介
市場ESG表現
RNA定序產業的ESG實踐
環境績效
社會表現
管治績效
BCC的結語

第8章附錄

調查方法
參考
縮寫詞
公司簡介
10X GENOMICS
AGILENT TECHNOLOGIES INC.
BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
BIO-RAD LABORATORIES INC.
BGI
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
INTEGRATED DNA TECHNOLOGIES INC.
MICROSYNTH AG
OXFORD NANOPORE TECHNOLOGIES PLC.
QIAGEN
REVVITY
STANDARD BIOTOOLS
THERMO FISHER SCIENTIFIC INC.

簡介目錄圖表

Product Code: BIO147B

The global market for RNA sequencing is expected to grow from $4.3 billion in 2024 and is projected to reach $10.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.1% during the forecast period of 2024 to 2029.

The global market for tools and reagents for RNA sequencing is expected to grow from $3.0 billion in 2024 and is projected to reach $7.4 billion by the end of 2029, at a CAGR of 19.6% during the forecast period of 2024 to 2029.

The global market for instruments for RNA sequencing is expected to grow from $645.6 million in 2024 and is projected to reach $1.5 billion by the end of 2029, at a CAGR of 18.2% during the forecast period of 2024 to 2029.

Report Scope:

This research report covers the global market for RNA sequencing. It incorporates an in-depth analysis of the RNA sequencing market, including market estimates and trends through 2029. For this analysis, the market has been segmented based on products, technologies, applications, end users and regions. In terms of geographical region, the market is divided into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). For market estimates, data has been provided for the base year 2023, with forecasts for 2024 through 2029.

This report also examines strategies and collaborations, discusses the regulatory landscape and analyzes macroeconomic factors when considering new technologies, the industry's growing competition and changing customer needs. It also includes various analytical frameworks, such as ESG analysis, competitive analysis and strategic recommendations, that will help companies operating within this market devise their strategic plan of action.

Report Includes:

65 data tables and 57 additional tables
A review of the global market and technologies for RNA sequencing
Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
Evaluation of the overall market for RNA sequencing, and corresponding market share analysis by product, technology, application, end-user and region
Discussion of recent RNA sequencing approaches such as next-generation sequencing (NGS) technology, single nucleotide polymorphism (SNP) discovery, RNA editing, and Sanger sequencing technology
Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
Analysis of the regulatory landscape and macroeconomic factors impacting the market
Coverage of the most recent approvals, recalls, safety alerts and clinical trials
Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings, and consumer attitudes
Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
Profiles of the leading companies, including Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., and Qiagen

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Overview
Technology Background
Transcriptomics Technologies
RNA Sequencing for Transcriptomics
RNA-Seq Experimental Workflow
RNA-Seq Workflow Considerations
Steps to Select the Right Platform for RNA Sequencing
Regulatory Landscape
Growth Strategy Recommendations

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Rapid Advances in Data Analysis Capabilities
Favorable Funding Scenario for Genomics and Biomedical Research Activities
Decline in the Prices of Genome Sequencing
Growing Prevalence of Cancer Generating Demand for Personalized Treatments
Market Restraints
Lack of Data Standardization
Cost vs. Coverage Challenges
Market Opportunities
Harnessing Blockchain and Cloud Computing Technologies
Technological Advances in RNA Isolation and Extraction Processes

Chapter 4 Emerging Technologies and Developments

Single-Cell RNA Sequencing
Other Emerging Single-Cell Technologies

Chapter 5 Market Segmentation Analysis

Key Market Trends
Segmentation Breakdown
Global Market for RNA Sequencing by Product
Instruments
Tools and Reagents
Software and Services
Global Market for RNA Sequencing by Technology
Sequencing by Synthesis
Ion Torrent Semiconductor Sequencing
Single-Molecule Real-Time Sequencing
Nanopore Sequencing
Global Market for RNA Sequencing by Application
Expression Profiling Analysis
Small RNA Sequencing
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
Global Market for RNA Sequencing by End User
Academic Research Organizations
Pharmaceutical and Biotechnology Companies
Clinical and Hospital Laboratories
Other End Users
Geographic Breakdown
Global RNA Sequencing Market by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence

Overview
Ranking of Leading Market Players
Key Strategies Adopted by Players
Collaborations and Agreements
New Product Launches
Partnerships
Expansions
Mergers and Acquisitions
The Role of CROs in RNA Sequencing Data Generation
Leading RNA Sequencing Service Providers

Chapter 7 Sustainability in RNA Sequencing Market: ESG Perspective

Introduction to ESG
ESG Performance in the Market
ESG Practices in the RNA Sequencing Industry
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC Research

Chapter 8 Appendix

Methodology
References
Acronyms
Company Profiles
10X GENOMICS
AGILENT TECHNOLOGIES INC.
BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
BIO-RAD LABORATORIES INC.
BGI
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
INTEGRATED DNA TECHNOLOGIES INC.
MICROSYNTH AG
OXFORD NANOPORE TECHNOLOGIES PLC.
QIAGEN
REVVITY
STANDARD BIOTOOLS
THERMO FISHER SCIENTIFIC INC.

簡介目錄圖表

List of Tables

Summary Table A : Global Market for RNA Sequencing, by Product, Through 2029
Summary Table B : Global Market for RNA Sequencing, by Technology, Through 2029
Table 1 : Types of RNAs in Cells
Table 2 : Comparison of Transcriptomics Methods
Table 3 : Functional Elements in Sequencing Adapters
Table 4 : Publicly Available Transcriptomics Data in the Cancer Research Field
Table 5 : Overview of Illumina's Sequencing Instruments
Table 6 : Global Market for RNA Sequencing for Instruments, by Region, Through 2029
Table 7 : Global Market for RNA Sequencing for Tools and Reagents, by Region, Through 2029
Table 8 : rRNA Depletion Kits
Table 9 : mRNA Enrichment Kits
Table 10 : Global Market for RNA Sequencing Sample Preparation for Tools & Reagents, by Region, Through 2029
Table 11 : RNA Sequencing Kits for Illumina Platform
Table 12 : Thermo Fisher RNA Sequencing Products for Ion Torrent
Table 13 : Thermo Fisher's RNA Sequencing Library Prep Kits for SOLiD
Table 14 : Global Market for RNA Sequencing Library Preparation for Tools and Reagents, by Region, Through 2029
Table 15 : Cloud Computing Providers for Genomics/RNA-Seq
Table 16 : Global Market for RNA Sequencing for Software and Services, by Region, Through 2029
Table 17 : RNA Sequencing Applications on Illumina Platforms
Table 18 : Global Market for RNA Sequencing for Sequencing by Synthesis, by Region, Through 2029
Table 19 : RNA Sequencing Applications on Ion Torrent Systems
Table 20 : Global Market for RNA Sequencing for Ion Torrent Semiconductor, by Region, Through 2029
Table 21 : PacBio RNA-Seq Applications
Table 22 : PacBio RNA-Seq Workflow
Table 23 : Global Market for RNA Sequencing for Single-Molecule Real-Time Sequencing, by Region, Through 2029
Table 24 : Global Market for RNA Sequencing for Nanopore Sequencing, by Region, Through 2029
Table 25 : Global Market for RNA Sequencing for Expression Profiling Analysis, by Region, Through 2029
Table 26 : Small RNA-Seq on Illumina Platforms
Table 27 : Global Market for RNA Sequencing for Small RNA Sequencing, by Region, Through 2029
Table 28 : Global Market for RNA Sequencing for De Novo Transcriptome Assembly, by Region, Through 2029
Table 29 : Global Market for RNA Sequencing for Variant Calling & Transcriptome Epigenetics, by Region, Through 2029
Table 30 : Global Market for RNA Sequencing for Academic Research Organizations, by Region, Through 2029
Table 31 : Global Market for RNA Sequencing for Pharmaceutical and Biotechnology Companies, by Region, Through 2029
Table 32 : Global Market for RNA Sequencing for Clinical and Hospital Laboratories, by Region, Through 2029
Table 33 : Global Market for RNA Sequencing for Other End Users, by Region, Through 2029
Table 34 : Global Market for RNA Sequencing, by Region, Through 2029
Table 35 : North American Market for RNA Sequencing, by Product, Through 2029
Table 36 : North American Market for RNA Sequencing for Tools & Reagents, by Type, Through 2029
Table 37 : North American Market for RNA Sequencing, by Technology, Through 2029
Table 38 : North American Market for RNA Sequencing, by Application, Through 2029
Table 39 : North American Market for RNA Sequencing, by End User, Through 2029
Table 40 : Research Initiatives Focused on Personalized Medicine in Europe
Table 41 : European Market for RNA Sequencing, by Product, Through 2029
Table 42 : European Market for RNA Sequencing for Tools and Reagents, by Type, Through 2029
Table 43 : European Market for RNA Sequencing, by Technology, Through 2029
Table 44 : European Market for RNA Sequencing, by Application, Through 2029
Table 45 : European Market for RNA Sequencing, by End User, Through 2029
Table 46 : Asia-Pacific Market for RNA Sequencing, by Product, Through 2029
Table 47 : Asia-Pacific Market for RNA Sequencing for Tools and Reagents, by Type, Through 2029
Table 48 : Asia-Pacific Market for RNA Sequencing, by Technology, Through 2029
Table 49 : Asia-Pacific Market for RNA Sequencing, by Application, Through 2029
Table 50 : Asia-Pacific Market for RNA Sequencing, by End User, Through 2029
Table 51 : RoW Market for RNA Sequencing, by Product, Through 2029
Table 52 : RoW Market for RNA Sequencing for Tools and Reagents, by Type, Through 2029
Table 53 : RoW Market for RNA Sequencing, by Technology, Through 2029
Table 54 : RoW Market for RNA Sequencing, by Application, Through 2029
Table 55 : RoW Market for RNA Sequencing, by End User, Through 2029
Table 56 : Leading Players in RNA Sequencing Market, 2023
Table 57 : Collaborations and Agreements in the RNA Sequencing Market, 2021-2024
Table 58 : New Product Launches in the RNA Sequencing Market, 2021-2024
Table 59 : Partnerships in the RNA Sequencing Market, 2022-2024
Table 60 : Expansions in the RNA Sequencing Market, 2020-2024
Table 61 : Mergers and Acquisitions in the RNA Sequencing Market, 2020-2024
Table 62 : Leading RNA Sequencing Service Providers
Table 63 : Key Focus Areas in ESG Metrics
Table 64 : Environmental Performance Initiatives in the RNA Sequencing Market
Table 65 : Social Performance Initiatives in RNA Sequencing Market
Table 66 : Governance Performance Initiatives in RNA Sequencing Market
Table 67 : ESG Rankings for Key Players in RNA Sequencing Market, 2024*
Table 68 : Acronyms Used in this Report
Table 69 : 10x Genomics: Company Snapshot
Table 70 : 10x Genomics: Financial Performance, FY 2022 and 2023
Table 71 : 10x Genomics: Product Portfolio
Table 72 : 10x Genomics: News/Key Developments, 2022 and 2023
Table 73 : Agilent Technologies Inc.: Company Snapshot
Table 74 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 75 : Agilent Technologies Inc.: Product and Services Portfolio
Table 76 : Agilent Technologies Inc.: News/Key Developments, 2021-2023
Table 77 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Company Snapshot
Table 78 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Product Portfolio
Table 79 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): News/Key Developments, 2022-2024
Table 80 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 81 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 82 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 83 : Bio-Rad Laboratories Inc.: News/Key Developments, 2022-2024
Table 84 : BGI: Company Snapshot
Table 85 : BGI: Product & Services Portfolio
Table 86 : BGI: News/Key Developments, 2024
Table 87 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 88 : F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 89 : F. Hoffman-La Roche Ltd.: Product Portfolio
Table 90 : F. Hoffman-La Roche Ltd.: News/Key Developments, 2021 and 2022
Table 91 : Illumina Inc.: Company Snapshot
Table 92 : Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 93 : Illumina Inc.: Product Portfolio
Table 94 : Illumina Inc.: News/Key Developments, 2022-2024
Table 95 : Integrated DNA Technologies Inc.: Company Snapshot
Table 96 : Integrated DNA Technologies Inc.: Product & Services Portfolio
Table 97 : Integrated DNA Technologies Inc.: News/Key Developments, 2021-2024
Table 98 : Microsynth AG: Company Snapshot
Table 99 : Microsynth AG: Product & Services Portfolio
Table 100 : Microsynth AG: News/Key Developments, 2022
Table 101 : Oxford Nanopore Technologies plc.: Company Snapshot
Table 102 : Oxford Nanopore Technologies plc.: Financial Performance, FY 2022 and 2023
Table 103 : Oxford Nanopore Technologies plc.: Product Portfolio
Table 104 : Oxford Nanopore Technologies plc.: News/Key Developments, 2022-2024
Table 105 : QIAGEN: Company Snapshot
Table 106 : QIAGEN: Financial Performance, FY 2022 and 2023
Table 107 : QIAGEN: Product Portfolio
Table 108 : QIAGEN: News/Key Developments, 2022-2024
Table 109 : Revvity: Company Snapshot
Table 110 : Revvity: Financial Performance, FY 2022 and 2023
Table 111 : Revvity: Product Portfolio
Table 112 : Revvity: News/Key Developments, 2023
Table 113 : Standard BioTools: Company Snapshot
Table 114 : Standard BioTools: Financial Performance, FY 2022 and 2023
Table 115 : Standard BioTools: Product Portfolio
Table 116 : Standard BioTools: News/Key Developments, 2022-2024
Table 117 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 118 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 119 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 120 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2024

List of Figures

Summary Figure A : Global Market for RNA Sequencing, by Product, 2021-2029
Summary Figure B : Global Market for RNA Sequencing, by Technology, 2021-2029
Figure 1 : RNA-Seq Experiments for Transcriptomics
Figure 2 : RNA-Seq Experimental Workflow
Figure 3 : RNA-Seq Workflow Considerations
Figure 4 : Factors Related to Selecting the Right Platform for RNA-Seq
Figure 5 : Growth Strategy Recommendations: RNA Sequencing Market
Figure 6 : Market Dynamics
Figure 7 : Average Cost Per Genome: Y-o-Y Trend, 2011-2022
Figure 8 : Global Market Shares of RNA Sequencing, by Product, 2024
Figure 9 : Global Market for RNA Sequencing for Instruments, by Region, 2021-2029
Figure 10 : Global Market for RNA Sequencing for Tools and Reagents, by Region, 2021-2029
Figure 11 : Global Market for RNA Sequencing Sample Preparation for Tools & Reagents, by Region, 2021-2029
Figure 12 : Global Market for RNA Sequencing Library Preparation for Tools and Reagents, by Region, 2021-2029
Figure 13 : Global Market for RNA Sequencing for Software and Services, by Region, 2021-2029
Figure 14 : Global Market Shares of RNA Sequencing, by Technology, 2024
Figure 15 : Global Market for RNA Sequencing for Sequencing by Synthesis, by Region, 2021-2029
Figure 16 : Global Market for RNA Sequencing for Ion Torrent Semiconductor, by Region, 2021-2029
Figure 17 : Global Market for RNA Sequencing for Single-Molecule Real-Time Sequencing, by Region, 2021-2029
Figure 18 : Global Market for RNA Sequencing for Nanopore Sequencing, by Region, 2021-2029
Figure 19 : Major Applications of RNA Sequencing
Figure 20 : Global Market Shares of RNA Sequencing, by Application, 2024
Figure 21 : Global Market for RNA Sequencing for Expression Profiling Analysis, by Region, 2021-2029
Figure 22 : Global Market for RNA Sequencing for Small RNA Sequencing, by Region, 2021-2029
Figure 23 : Global Market for RNA Sequencing for De Novo Transcriptome Assembly, by Region, 2021-2029
Figure 24 : Global Market for RNA Sequencing for Variant Calling & Transcriptome Epigenetics, by Region, 2021-2029
Figure 25 : Global Market Shares of RNA Sequencing, by End User, 2024
Figure 26 : Global Market for RNA Sequencing for Academic Research Organizations, by Region, 2021-2029
Figure 27 : Role of RNA Sequencing in Drug Development
Figure 28 : Global Market for RNA Sequencing for Pharmaceutical and Biotechnology Companies, by Region, 2021-2029
Figure 29 : Global Market for RNA Sequencing for Clinical and Hospital Laboratories, by Region, 2021-2029
Figure 30 : Global Market for RNA Sequencing for Other End Users, by Region, 2021-2029
Figure 31 : Global Market Shares of RNA Sequencing, by Region, 2024
Figure 32 : North American Market for RNA Sequencing, by Product, 2021-2029
Figure 33 : North American Market for RNA Sequencing for Tools & Reagents, by Type, 2021-2029
Figure 34 : North American Market for RNA Sequencing, by Technology, 2021-2029
Figure 35 : North American Market for RNA Sequencing, by Application, 2021-2029
Figure 36 : North American Market for RNA Sequencing, by End User, 2021-2029
Figure 37 : European Market for RNA Sequencing, by Product, 2021-2029
Figure 38 : European Market for RNA Sequencing for Tools and Reagents, by Type, 2021-2029
Figure 39 : European Market for RNA Sequencing, by Technology, 2021-2029
Figure 40 : European Market for RNA Sequencing, by Application, 2021-2029
Figure 41 : European Market for RNA Sequencing, by End User, 2021-2029
Figure 42 : Growth Drivers in Asia-Pacific RNA Sequencing Market
Figure 43 : Asia-Pacific Market for RNA Sequencing, by Product, 2021-2029
Figure 44 : Asia-Pacific Market for RNA Sequencing for Tools and Reagents, by Type, 2021-2029
Figure 45 : Asia-Pacific Market for RNA Sequencing, by Technology, 2021-2029
Figure 46 : Asia-Pacific Market for RNA Sequencing, by Application, 2021-2029
Figure 47 : Asia-Pacific Market for RNA Sequencing, by End User, 2021-2029
Figure 48 : RoW Market for RNA Sequencing, by Product, 2021-2029
Figure 49 : RoW Market for RNA Sequencing for Tools & Reagents, by Type, 2021-2029
Figure 50 : RoW Market for RNA Sequencing, by Technology, 2021-2029
Figure 51 : RoW Market for RNA Sequencing, by Application, 2021-2029
Figure 52 : RoW Market for RNA Sequencing, by End User, 2021-2029
Figure 53 : Global Market Shares of RNA Sequencing, by Key Strategies Adopted, 2020-2024
Figure 54 : How a Strong ESG Proposition Benefits Businesses
Figure 55 : Percentage of Biotech Companies Providing ESG Disclosure, 2022
Figure 56 : Location of ESG Disclosure, 2022
Figure 57 : 10x Genomics: Revenue Shares, by Country/Region, FY 2023
Figure 58 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 59 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 60 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 61 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 62 : F. Hoffman-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 63 : F. Hoffman-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2023
Figure 64 : Illumina Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 65 : Illumina Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 66 : Oxford Nanopore Technologies plc.: Revenue Shares, by Business Unit, FY 2023
Figure 67 : Oxford Nanopore Technologies plc.: Revenue Shares, by Country/Region, FY 2023
Figure 68 : QIAGEN: Revenue Shares, by Business Unit, FY 2023
Figure 69 : QIAGEN: Revenue Shares, by Country/Region, FY 2023
Figure 70 : Revvity: Revenue Shares, by Business Unit, FY 2023
Figure 71 : Revvity: Revenue Shares, by Country/Region, FY 2023
Figure 72 : Standard BioTools: Revenue Shares, by Business Unit, FY 2023
Figure 73 : Standard BioTools: Revenue Shares, by Country/Region, FY 2023
Figure 74 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 75 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023